TransMedics(TMDX) - 2024 Q2 - Quarterly Results

Exhibit 99.1 TransMedics Reports Second Quarter 2024 Financial Results Andover, Mass. – July 31, 2024 – TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today reported financial results for the quarter ended June 30, 2024. Recent Highlights ▪ Total revenue of $114.3 million in the second quarter of 2024, a 118% increase compared to the second quarter of 2023 ▪ Generat ...